Biocon, an India-based biopharmaceutical company, has entered into an exclusive licensing and supply agreement with Brazilian specialty pharmaceutical company Biomm for the commercialisation of Semaglutide (gOzempic), a drug used to improve glycemic control in adults with type-2 diabetes.
Sanofi India Limited and Sanofi Healthcare India (together called “Sanofi India”) have entered into an exclusive partnership with Cipla, focusing on the expansion of its central nervous system (CNS) product portfolio in the Indian market.
Merck has announced the opening of a new €20m ($21.7m) distribution centre in Cajamar, São Paulo, Brazil, for serving its Life Science customers in the region.
Aizon, an artificial intelligence (AI) Software as a Service (SaaS) provider for pharmaceutical manufacturing operations, has secured $20m in Series C funding to expedite its development pipeline.
Kindeva Drug Delivery, a provider of drug-device combination products, has announced the acquisition of Summit Biosciences, an intranasal drug-delivery contract development and manufacturing organisation (CDMO).
Eurofins CDMO Alphora has announced the completion of a new pilot-scale biologics development facility in Canada.
AGC Biologics has announced the establishment of a new manufacturing site at the AGC Yokohama Technical Center in Japan.
Lavipharm has signed an agreement with Sanofi to acquire the pharmaceutical product, Flagyl, for the Greek market, for an undisclosed sum.
Aurinia Pharmaceuticals’ collaboration partner Otsuka Pharmaceutical has submitted a new drug application (NDA) to the Japanese Ministry of Health, Labour and Welfare for voclosporin to treat lupus nephritis (LN).
Mithra Pharmaceuticals has entered into a license and supply agreement with Searchlight Pharma for the Canadian rights to Donesta.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.